StockData
Medtronic plc logo

Medtronic plc (MDT) operating KPIs

MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)

Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%

Medtronic clinicalTrials.gov Newly Started Studies — Medtronic

NIH ClinicalTrials.gov API v2 (1,675 Lead-Sponsor Medtronic Studies)

Latest, FY2026
49
Period ended Apr 30, 2026
Change on a year earlier
+22.5%
40 in FY2025
History
12 years
Since FY2015
Sources
1
NIH ClinicalTrials.gov Registry — Medtronic

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Breakdown

What makes up clinicaltrials.gov newly started studies — medtronic

Cite this data

StockData. (2026). Medtronic ClinicalTrials.gov Newly Started Studies — Medtronic, annual FY2015–FY2026 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/ext-ct-started

See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.